Healthcare / Health Information ServicesStockholm
$0.13
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-4.5M · quality 61.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
23/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$26M
P/E
N/A
•EV/EBITDA
N/A
•ROE
95.1%
↑Gross Margin
51.0%
↑Debt/Equity
-1.30
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+9.5%
FCF CAGR
—
FCF margin
-9.2%
FCF / Net income
0.40x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $26.1M · net income $-6.1M · FCF $-2.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $26.1M | $26.1M | $23.9M | $23.9M | $19.9M |
| Net Income | $-6.1M | $-6.1M | $-9.9M | $-10.7M | $-15.0M |
| EBITDA | $-2.4M | $-2.4M | $-6.1M | $-6.6M | $-11.3M |
| EPS | — | — | -0.10 | -0.08 | -0.07 |
| Gross Margin | 51.0% | 51.0% | 43.4% | 40.6% | 28.9% |
| Operating Margin | -20.1% | -20.1% | -38.6% | -44.6% | -73.1% |
| Net Margin | -23.4% | -23.4% | -41.4% | -44.6% | -75.2% |
| Balance Sheet | |||||
| Debt/Equity | -1.30 | -1.30 | -0.37 | -0.19 | -0.29 |
| Current Ratio | 0.73 | 0.73 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-2.4M | $-2.4M | $-4.5M | $-6.3M | $-12.9M |
| Returns | |||||
| ROE | 95.1% | 95.1% | 2164.8% | 1252.8% | 669.7% |
| Growth & Yield | |||||
| Revenue Growth | 9.1% | 9.1% | 0.1% | 20.1% | — |
| EPS Growth | — | — | -18.0% | -26.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-37.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.10 → n/d
Residual
-37.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.